3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Uterine Cervical Neoplasms
1
Sarcoma, Ewing
1
Recurrence
1
Ovarian Neoplasms
1
Osteosarcoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma
1
HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer
1
Chondrosarcoma
1
Interventions
Methotrexate
5
Drug Therapy
5
apatinib
4
Neoadjuvant Therapy
4
Doxorubicin
3
camrelizumab
2
Ifosfamide
2
Cisplatin
2
trilaciclib
1
spartalizumab
1
palbociclib
1
isophosphamide mustard
1
irinotecan sucrosofate
1
glucarpidase
1
endostar protein
1
Zoledronic Acid
1
Vinorelbine
1
Triptorelin Pamoate
1
Trabectedin
1
Therapeutics
1
Thalidomide
1
TQ-B3525
1
Psychiatric Rehabilitation
1
Nivolumab
1
Neuropsychological Tests
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Microbiota
1
Metabolome
1
Magnetic Resonance Spectroscopy
1
Lithium Carbonate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Osteosarcoma
×
TQ-B3525
×
Clear all
NCT04690725
2020-12-31
TQBSP
Peking University People's Hospital
Phase 1/2
Unknown
29 enrolled